Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...

With the help of mRNA technology proven effective during the COVID era, researchers are now closer than ever to creating ...

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.

Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation HONG KONG, Mar 7, 2025 - (ACN Newswire) - </strong ...

Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...

Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...

mRNA cancer vaccines work by giving the body ... send it to the pharmaceutical company, and they design a personalized vaccine that’s bespoke to that patient’s cancer. That vaccine is not ...

This acquisition combines Officinae Bio's AI-enabled mRNA design platforms with Maravai and TriLink BioTechnologies' leading drug substance manufacturing capabilities, providing customers ...